Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells

J Immunol. 2007 Dec 15;179(12):8235-42. doi: 10.4049/jimmunol.179.12.8235.

Abstract

In this study, we characterize the molecular signal pathways that lead to MHC class I chain-related protein A (MICA) expression after histone deacetylase (HDAC)-inhibitor (HDAC-i) treatment of Jurkat T cells. Chelating calcium with BAPTA-AM or EGTA potently inhibited HDAC- and CMV-mediated MICA/B expression. It was further observed that endoplasmic reticulum calcium stores were depleted after HDAC treatment. NF-kappaB activity can be induced by HDAC treatment. However, nuclear translocation of NF-kappaB p65 was not observed after HDAC treatment of Jurkat T cells and even though we could effectively inhibit p65 expression by siRNA, it did not modify MICA/B expression. To identify important elements in MICA regulation, we made a promoter construct consisting of approximately 3 kb of the proximal MICA promoter in front of GFP. Deletion analysis showed that a germinal center-box containing a putative Sp1 site from position -113 to -93 relative to the mRNA start site was important for HDAC and CMV-induced promoter activity. Sp1 was subsequently shown to be important, as targeted mutation of the Sp1 binding sequence or siRNA mediated down modulation of Sp1-inhibited MICA promoter activity and surface-expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Calcium / antagonists & inhibitors
  • Calcium / metabolism
  • Chelating Agents / pharmacology
  • Cytomegalovirus / genetics
  • Depsipeptides / pharmacology
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Endoplasmic Reticulum / metabolism
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation*
  • Histocompatibility Antigens Class I / genetics*
  • Histocompatibility Antigens Class I / metabolism
  • Histone Deacetylase Inhibitors*
  • Humans
  • Jurkat Cells
  • Promoter Regions, Genetic
  • RNA, Small Interfering / genetics
  • Sp1 Transcription Factor / metabolism
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / immunology*
  • Transcription Factor RelA / metabolism

Substances

  • Chelating Agents
  • Depsipeptides
  • Enzyme Inhibitors
  • Histocompatibility Antigens Class I
  • Histone Deacetylase Inhibitors
  • MHC class I-related chain A
  • MICB antigen
  • RNA, Small Interfering
  • Sp1 Transcription Factor
  • Transcription Factor RelA
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Egtazic Acid
  • romidepsin
  • Calcium